SHELBY PRIMEAUX: Open Payments
NPI 1942870910 · VICKSBURG, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$828 in 42 payments from 15 companies in 2025. Trend: 2023 $690 · 2024 $741 · 2025 $828
Food & beverage: $828
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 7 | $163 |
| Merck Sharp & Dohme LLC | 9 | $157 |
| Novartis Pharmaceuticals Corporation | 7 | $139 |
| PFIZER INC. | 4 | $64 |
| Kestra Medical Technology Services, Inc. | 2 | $57 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $55 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 2 | $34 |
| Novo Nordisk Inc | 1 | $28 |
| GlaxoSmithKline, LLC. | 1 | $24 |
| SCPHARMACEUTICALS INC. | 1 | $23 |
Products named: Kerendia, VERQUVO, LEQVIO, ELIQUIS, Assure WCD, JARDIANCE, LifeVest, Wegovy.
Industry payments across MS — which companies pay providers there.
